Key facts
- It has raised $200K; the latest was Early Stage VC ($200K) in Jun 2025.
- Notable investors include Innovation Works, LifeX Ventures, Notre Dame Venture Capital, Robotics Factory.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Thio (Enterprise Systems (Healthcare))
- ·The full record, as it builds
Funding rounds
No funding rounds for Thio (Enterprise Systems (Healthcare)) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Thio (Enterprise Systems (Healthcare))
Developer of pharmacy software designed to improve medication management. The company's platform leverages technologies like IoT sensing, AI, cloud computing, and mobile apps to create scalable and user-friendly grab-and-go systems, enabling pharmacy companies to offer a more agile, intuitive, equitable, and efficient healthcare experience.
- Sector
- Healthcare
- HQ
- Pittsbugh, PA, United States
- Founded
- 2023
- Employees
- 2
- Website
- thiopoly.com/
- Ownership
- Privately Held (backing)
Thio (Enterprise Systems (Healthcare)) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Thio (Enterprise Systems (Healthcare)) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Thio (Enterprise Systems (Healthcare)) in its N-PORT filings yet. We sweep new filings monthly.